Korean Journal of Nuclear Medicine Technology (Korean J Nucl Med Technol)

Open access, Peer Reviewed

Indexed in KCI, DOAJ

pISSN 1229-9901
eISSN 2982-8406

Original article

Evaluation of Regional Radiopharmaceutical Distribution Using a Lead-Collimated Survey Meter in Bone Scintigraphy

Department of Nuclear Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea

Correspondence to Sang-Hyeong Kil, Department of Nuclear Medicine, Pusan National University Yangsan Hospital, 20, Geumo-ro, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do, 50612, Republic of Korea. Tel: +82-55-360-1901, E-mail: rlf1007@naver.com

Volume 30, Number 2, Article 21, November 2026. Korean J Nucl Med Technol 2026;30(2):21. https://doi.org/10.12972/kjnmt.2026.30.2.21
Received on October 07, 2026, Revised on October 25, 2026, Accepted on October 28, 2026, Published on November 30, 2026.
This is an Open Access article distributed under the terms of the Creative Commons CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose: Handheld survey meters detect photons from both the target region and surrounding tissues, which limits their regional specificity. This study evaluated whether lead collimation strengthens the association between regional survey meter ratios and gamma camera count ratios in patients undergoing 99mTc-DPD bone scintigraphy. Materials and Methods: In this single-center paired-measurement study, 68 adult patients underwent anterior pelvic imaging, followed by survey meter measurements over the bladder, proximal femur, and adjacent soft tissue using an energy-compensated Geiger–Müller survey meter. Measurements were obtained under three conditions: with a 6-mm-thick lead collimator at a detector center-to-skin distance of 10 cm (COL); with a paper replica of identical geometry but without lead shielding (NCOL); and with the detector housing in direct contact with the skin (CONTACT). Bladder-to-soft-tissue ratios (BSRs) and femur-to-soft-tissue ratios (FSRs) were calculated from gamma camera counts and background-corrected dose rates. Spearman correlations were assessed with patient-level bootstrap confidence intervals and Holm correction for six tests. The pre-specified comparison of BSR correlations between the collimated and uncollimated conditions was performed using paired bootstrapping. Results: The bladder-to-soft-tissue ratio correlation was strongest under the collimator condition (ρ = 0.597; Holm-adjusted P < 0.001), followed by the skin contact (ρ = 0.416; adjusted P = 0.002) and uncollimated conditions (ρ = 0.299; adjusted P = 0.053). The correlation was significantly higher under the collimator than under the uncollimated condition (Δρ = 0.298; P = 0.022), whereas the collimated and skin-contact conditions difference was not significant (P = 0.188). Femur-to-soft-tissue ratio correlations were not significant under any condition. The association between the collimated survey meter bladder-to-soft-tissue ratio and the gamma camera bladder-to-soft-tissue ratio persisted after adjustment for sex, administered activity, and injection-to-imaging interval (partial ρ = 0.558; P < 0.001). Conclusion: Under matched geometry, lead collimation strengthened the association between survey meter and gamma camera bladder-to-soft-tissue ratios. These findings suggest that a lead-collimated survey meter may serve as a supplementary tool for assessing regional radiopharmaceutical distribution in the bladder, potentially supporting pre-imaging assessment and helping reduce the need for repeat bone scintigraphy.
Keywords
99mTc-DPD, Bone Scintigraphy, Radiation Survey Meter, Lead Collimator, Regional Activity Distribution
Section